TerrAscend Stock (CSE: TER) (OTCQX: TRSSF) - Investor Dashboard

Summary

Financials (09/30/19)

Capital Structure (11/20/19)

Company Brief

TerrAscend provides quality products, brands, and services to the global cannabinoid market. As the first North American Operator (NAO), with scale operations in both Canada and the US, the Company participates in the medical and legal adult use market across Canada and in several US states where cannabis has been legalized for therapeutic or adult use. Additionally, TerrAscend is the first and only cannabis company with sales in Europe as well as the US and Canada as it has received EU GMP certification for its manufacturing facility in Mississauga, Ontario.

TerrAscend operates a number of synergistic businesses, including The Apothecarium, an award-winning cannabis dispensary with several retail locations in California and Nevada; Ilera Healthcare, Pennsylvania’s premier medical marijuana cultivator, processor and dispenser; Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ascendant Laboratories Inc., a biotechnology and licensing company committed to the continuous improvement of cannabinoid expressing plants; and Solace RX Inc., a proposed Drug Preparation Premises (DPP) focused on the development of novel formulations and delivery forms. Additionally, TerrAscend has been chosen by the state of New Jersey to be one of six permit applicants for a vertically integrated medical cannabis operation.

A Strong Growth Platform

April 25, 2019 Investor Day Webcast

Highlights

• Canadian LP with global distribution, multi-state operator in the U.S., and nationwide distributor of hemp-derived CBD products
• Strategic investors include Canopy Growth, Canopy Rivers, and JW Funds
• Management comprised of leaders from healthcare, pharmaceutical, banking, cannabis and online grocery industries
• Strong pharmaceutical and distribution expertise
• Unique ability to sell THC and CBD products within Canada, the U.S., and the European Union through TerrAscend’s manufacturing footprint
• Brand portfolio including premium cannabis Haven St., Valhalla Confections, Funky Farms CBD extracts, Original Hemp and Illera

Growth Strategy

• Focus on developing protectable intellectual property assets
• Creating quality brands that resonate with patients and consumers
• Multi-state operator (MSO) in the U.S. strongly positioned in the markets where it competes
• Canadian LP concentrating on production and manufacturing of cannabinoid products for medical and adult use consumers
• Global export from EU GMP certified indoor cannabis facility in Mississauga, Ontario, Canada
• U.S. nationwide distribution of hemp-derived CBD products through Arise Bioscience

Differentiators

• First operator with scaled operations in both the U.S. and Canada, and first and only cannabis company with sales in the U.S., Canada and Europe
• In the U.S., executing a focused MSO strategy with strong assets and competitive positioning in the markets it serves
• One of six entities granted a permit to apply for a vertically integrated license in New Jersey, with TerrAscend located in the attractive North region
• Significant market share in Pennsylvania’s limited license market via Ilera Healthcare, one of five super license holders in the state
• Experienced leadership team with deep ties to global pharmaceutical distribution
• Developing drug preparation premises (DPP) facility for non-cannabinoid formulations
• Leverage proximity to Toronto to distribute on behalf of third-party LPs, with same-day delivery capabilities
• Wholesale supply agreements with seven Canadian provinces
• Proven consolidator with M&A expertise in the highly fragmented U.S. cannabis industry

Advancing Research

• Emphasis on developing protectible intellectual property
• Advancing plant genetics and product formulations
• Pharma-grade manufacturing facility

Building Brands

• Developing trusted and recognized brands
• Addressing needs of multiple cannabis business streams
• Defining brands based on deep consumer insights

Promoting Responsibility

• Ensuring highest standard of ethics and corporate integrity
• Advocating responsible use of products
• Exceeding industry and regulatory standards

Optimizing Wellness

• Providing support for medical cannabis use
• Guiding cannabis selection and consumption preferences
• Enhancing the therapeutic application of cannabinoids

Robert Fagan
GMP Securities

Noel Atkinson
Clarus Securities